COVID-19 Reagent Antibodies

Overview

As the global COVID-19 pandemic rages around the world, the need to rapidly develop effective solutions to prevent and treat this disease is of critical importance. To fight this disease, GenScript has a wide range of SARS-CoV-2 control antibodies available on demand to accelerate the research and development of COVID-19 vaccines, diagnostics, and neutralizing antibody therapies.

Over 50 SARS-CoV-2 Control mAbs Available on Demand

Perfect as mAb controls for virus neutralization assays, IVD development, as well as vaccine & infectious disease research! Our mAbs are available at scalable quantities. We are able to handle bulk quantities (> 1 mg), and convert these into chimeric mAbs on request.